Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales: Collette, Y, Prébet, T, Goubard, A, Adélaïde, J, Castellano, R, Carbuccia, N, Garnier, S, Guille, A, Arnoulet, C, Charbonier, A, Mozziconacci, M J, Birnbaum, D, Chaffanet, M, Vey, N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382656/
https://www.ncbi.nlm.nih.gov/pubmed/25768406
http://dx.doi.org/10.1038/bcj.2015.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382656/
https://www.ncbi.nlm.nih.gov/pubmed/25768406
http://dx.doi.org/10.1038/bcj.2015.13

Ejemplares similares